Skip to main content

Whitehead Scans Liver and Pancreas Genomes for Diabetes Clues

NEW YORK, Feb. 27 (GenomeWeb News) - Scientists from the Whitehead Institute for Biomedical Research have published a study in today's issue of Science, in which they describe a method for scanning the genomes of human liver and pancreas in order to map the location of gene regulators that are known to be involved in type 2 diabetes.

 

The genome scanning technology is a modified version of a technology used to identify the role of transcription factors in the yeast genome, first reported in Science in October 2002. This is the first time the technology has been applied to human organs, according to Whitehead.

 

The team of scientists, led by Richard Young - who developed the original technology - found that one transcription factor, HNF4, controls about half of the genes involved in developing the pancreas and liver. The gene is thought to be involved in type 2 diabetes.

 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.